Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period

Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations....

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Infectious Diseases Vol. 70; no. 6; pp. 642 - 646
Main Authors Shimotai, Yoshitaka, Itagaki, Tsutomu, Mizuta, Katsumi, Suzuki, Yu, Ikeda, Tatsuya, Hongo, Seiji, Seto, Junji, Matsuzaki, Yoko, Katsushima, Fumio, Katsushima, Yuriko
Format Journal Article
LanguageEnglish
Published Japan National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee 2017
Japan Science and Technology Agency
Subjects
Online AccessGet full text
ISSN1344-6304
1884-2836
1884-2836
DOI10.7883/yoken.JJID.2017.276

Cover

Loading…
Abstract Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13–16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary.
AbstractList Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13–16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary.
Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13-16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary.Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata, Japan. The results were examined by considering the combination of the P1 type and prevalence of macrolide resistance-associated mutations. Four-locus (Mpn13-16) MLVA classified 347 strains into 9 MLVA types, including 3 major types: 3-5-6-2, 4-5-7-2, and 4-5-7-3. All type 3-5-6-2 strains (77 strains) were P1 type 2 variants (2a or 2c), while types 4-5-7-2 (181 strains) and 4-5-7-3 (75 strains) were P1 type 1. MLVA type 4-5-7-2 strains circulated and were dominant until 2010, accounting for 88.4% of the 121 strains isolated between 2004 and 2010. The prevalence of types 4-5-7-3 and 3-5-6-2 strains increased rapidly in 2011 and 2012, respectively, resulting in cocirculation of 3 MLVA types, including type 4-5-7-2, between 2011 and 2013. The prevalence of macrolide resistance-associated mutations in MLVA types 4-5-7-2, 4-5-7-3, and 3-5-6-2 strains was 59.7% (108/181), 25.3% (19/75), and 0% (0/77), respectively. Because the prevalence of macrolide resistance-associated mutations differed by current MLVA types in Yamagata, continued surveillance combined with molecular typing and identification of macrolide resistance-associated mutations is necessary.
Author Matsuzaki, Yoko
Itagaki, Tsutomu
Ikeda, Tatsuya
Katsushima, Fumio
Suzuki, Yu
Seto, Junji
Katsushima, Yuriko
Hongo, Seiji
Mizuta, Katsumi
Shimotai, Yoshitaka
Author_xml – sequence: 1
  fullname: Shimotai, Yoshitaka
  organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine
– sequence: 1
  fullname: Itagaki, Tsutomu
  organization: Yamanobe Pediatric Clinic
– sequence: 1
  fullname: Mizuta, Katsumi
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 1
  fullname: Suzuki, Yu
  organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine
– sequence: 1
  fullname: Ikeda, Tatsuya
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 1
  fullname: Hongo, Seiji
  organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine
– sequence: 1
  fullname: Seto, Junji
  organization: Department of Microbiology, Yamagata Prefectural Institute of Public Health
– sequence: 1
  fullname: Matsuzaki, Yoko
  organization: Department of Infectious Diseases, Yamagata University Faculty of Medicine
– sequence: 1
  fullname: Katsushima, Fumio
  organization: Katsushima Pediatric Clinic
– sequence: 1
  fullname: Katsushima, Yuriko
  organization: Katsushima Pediatric Clinic
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29093323$$D View this record in MEDLINE/PubMed
BookMark eNqFkd2O0zAQhSO0iP2BJ0BClrjhghQ7dhKHu1X5a9UCQgsSV9HEmRYvjh1sR6gvx7Ph0lKJveFmbM9851iac5mdWWcxyx4zOqul5C927jva2XK5eDUrKKtnRV3dyy6YlCIvJK_O0p0LkVecivPsMoRbSouyZPRBdl40tOG84BfZr_Vkoh4N5iunpkC-gNfQpef7aejQkxuwPQ75JxwRIrm2YHZBB-I2ZL1TbjQQBiCjxWlwVgOSRXAGIgbSYfyJaElBqSDJJF2YINqSrzDAFiI8J0sYwb4k829gt7gfrZ1BNRnw-54HFdHrELUKpJ-8ttvkQxjLd5iIj2nm-ofZ_Q2YgI-O51X2-c3rm_m7fPXh7WJ-vcpVxWTMN10joek5LzHVBqQCCr2EvgLguOmYrCtWlV1fVEXdybIWsldCNiWtlEg9fpU9O_iO3v2YMMR20EGhMWDRTaFlTdnwgklRJfTpHfTWTT4tLrRpBZyJRjQyUU-O1NQN2Lej1wP4Xfs3mQTwA6C8C8Hj5oQw2u7zb__k3-7z3xvXbco_qZo7KqUjRO1s9KDNf7SLg_Y2RNji6T_wKQKDR01N22pf_tGeGJVya9Hy39ca0lo
CitedBy_id crossref_primary_10_1016_j_jfma_2022_05_001
crossref_primary_10_3389_fcimb_2021_675466
crossref_primary_10_1016_j_jgar_2021_10_003
crossref_primary_10_1089_mdr_2018_0295
crossref_primary_10_1099_jmm_0_000969
crossref_primary_10_1128_JCM_00049_19
crossref_primary_10_1016_j_jfma_2019_12_008
crossref_primary_10_1093_ofid_ofab416
crossref_primary_10_1128_JCM_00710_20
crossref_primary_10_3201_eid2408_180081
crossref_primary_10_1016_j_ijid_2019_03_028
crossref_primary_10_1016_j_ijmmb_2023_100435
crossref_primary_10_1371_journal_pone_0209938
crossref_primary_10_3390_jcm11030715
crossref_primary_10_1007_s10096_019_03717_6
Cites_doi 10.1099/jmm.0.046441-0
10.1371/journal.pone.0174701
10.1128/JCM.03366-13
10.1097/00006454-199506000-00002
10.1128/AAC.48.2.460-465.2004
10.1128/JCM.00105-11
10.11150/kansenshogakuzasshi.89.16
10.1128/JCM.00350-17
10.1093/ofid/ofv106
10.1086/511159
10.7883/yoken.JJID.2014.336
10.1371/journal.pone.0082174
10.1128/JCM.01983-15
10.1128/JCM.01156-15
10.3389/fmicb.2016.00974
10.1097/INF.0b013e31827aa7bd
10.1111/j.1574-6976.2008.00129.x
10.1128/JCM.01935-08
10.1093/clinids/17.Supplement_1.S37
10.2217/fmb-2016-0111
10.1017/S0950268899003313
10.1371/journal.pone.0170253
10.3201/eid2103.140927
10.1128/JCM.02597-14
10.1371/journal.pone.0064607
10.1128/JCM.34.2.447-449.1996
10.1111/j.1348-0421.2001.tb01293.x
10.1016/j.nmni.2015.05.005
10.1128/JB.06553-11
10.1128/CMR.17.4.697-728.2004
10.1111/j.1440-1843.2003.00522.x
ContentType Journal Article
Copyright Authors
Copyright Japan Science and Technology Agency 2017
Copyright_xml – notice: Authors
– notice: Copyright Japan Science and Technology Agency 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
DOI 10.7883/yoken.JJID.2017.276
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1884-2836
EndPage 646
ExternalDocumentID 29093323
10_7883_yoken_JJID_2017_276
article_yoken_70_6_70_JJID_2017_276_article_char_en
Genre Historical Article
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
7.U
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
JSF
JSH
KQ8
OK1
OVT
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
ID FETCH-LOGICAL-c618t-fb98a9d335e9d39a8ca0ad8ad6aa3efb1876165bd2627b85748dc489506c42623
ISSN 1344-6304
1884-2836
IngestDate Thu Jul 10 19:54:46 EDT 2025
Mon Jun 30 12:03:05 EDT 2025
Thu Jan 02 23:10:19 EST 2025
Tue Jul 01 03:55:13 EDT 2025
Thu Apr 24 22:58:35 EDT 2025
Wed Sep 03 06:30:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords P1 type
molecular epidemiology
MLVA
VNTR
macrolide resistance
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c618t-fb98a9d335e9d39a8ca0ad8ad6aa3efb1876165bd2627b85748dc489506c42623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/yoken/70/6/70_JJID.2017.276/_article/-char/en
PMID 29093323
PQID 2013149498
PQPubID 2048383
PageCount 5
ParticipantIDs proquest_miscellaneous_1959321846
proquest_journals_2013149498
pubmed_primary_29093323
crossref_primary_10_7883_yoken_JJID_2017_276
crossref_citationtrail_10_7883_yoken_JJID_2017_276
jstage_primary_article_yoken_70_6_70_JJID_2017_276_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-00-00
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Japanese Journal of Infectious Diseases
PublicationTitleAlternate Jpn J Infect Dis
PublicationYear 2017
Publisher National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
Japan Science and Technology Agency
Publisher_xml – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
– name: Japan Science and Technology Agency
References 3. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17:S37-46.
10. Ho PL, Law PY, Chan BW, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560-4.
5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9:109-14.
31. Whistler T, Sawatwong P, Diaz MH, et al. Molecular characterization of Mycoplasma pneumoniae infections in two rural populations of Thailand from 2009 to 2012. J Clin Microbiol. 2017;55:2222-33.
12. Sun H, Xue G, Yan C, et al. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One. 2013;8:e64607.
18. Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974.
15. Kenri T, Horino A, Matsui M, et al. Complete genome sequence of Mycoplasma pneumoniae type 2a strain 309, isolated in Japan. J Bacteriol. 2012;194:1253-4.
6. Dégrange S, Cazanave C, Charron A, et al. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009;47:914-23.
14. Sasaki T, Kenri T, Okazaki N, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996;34:447-9.
33. Zhang J, Song X, Ma MJ, et al. Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data. Future Microbiol. 2017;12:119-29.
23. Kubota H, Okuno R, Hatakeyama K, et al. Moleculer typing of Mycoplasma pneumoniae isolated from pediatric patients in Tokyo, Japan. Jpn J Infect Dis. 2015;68:76-8.
8. Chalker VJ, Pereyre S, Dumke R, et al. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37-40.
19. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72.
26. Cousin-Allery A, Charron A, de Barbeyrac B, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124:103-11.
27. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-20.
20. Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53:124-30.
25. Suzuki Y, Itagaki T, Seto J, et al. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32:237-40.
11. Xue G, Wang Q, Yan C, et al. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J Clin Microbiol. 2014;52:1478-82.
2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
22. Suzuki Y, Seto J, Itagaki T, et al. Gene mutations associated with macrolide-resistance p1 gene typing of Mycoplasma pneumoniae isolated in Yamagata, Japan, between 2004 and 2013. Kansenshogaku Zasshi 2015;89:16-22. Japanese.
9. Sun H, Xue G, Yan C, et al. Changes in molecular characteristics of Mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One. 2017;12:e0170253.
17. Zhao F, Cao B, Li J, et al. Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J Clin Microbiol. 2011;49:3000-3.
7. Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol. 2016;7:693.
4. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471-7.
21. Dumke R, Schnee C, Pletz MW, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011–2012. Emerg Infect Dis. 2015;21:426-34.
1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-73.
24. Touati A, Blouin Y, Sirand-Pugnet P, et al. Molecular epidemiology of Mycoplasma pneumoniae: genotyping using single nucleotide polymorphisms and SNaPshot technology. J Clin Microbiol. 2015;53:3182-94.
32. Diaz MH, Desai HP, Morrison SS, et al. Comprehensive bioinformatics analysis of Mycoplasma pneumoniae genomes to investigate underlying population structure and type-specific determinants. PLoS One. 2017;12:e0174701.
28. Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48:460-5.
29. Ministry of Health, Labour and Welfare and National Institute of Infectious Disease. Mycoplasma Pneumonia. Available at <https://www.niid.go.jp/niid/en/10/2096-weeklygraph/1659-18 myco.html>. Accessed April 9, 2017. Japanese.
30. Qu J, Yu X, Liu Y, et al. Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One. 2013;8:e82174.
13. Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2:ofv106.
16. Kenri T, Ohya H, Horino A, et al. Identification of Mycoplasma pneumoniae type 2b variant strains in Japan. J Med Microbiol. 2012;61:1633-5.
22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-73.
– reference: 31. Whistler T, Sawatwong P, Diaz MH, et al. Molecular characterization of Mycoplasma pneumoniae infections in two rural populations of Thailand from 2009 to 2012. J Clin Microbiol. 2017;55:2222-33.
– reference: 10. Ho PL, Law PY, Chan BW, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560-4.
– reference: 13. Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2:ofv106.
– reference: 6. Dégrange S, Cazanave C, Charron A, et al. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009;47:914-23.
– reference: 12. Sun H, Xue G, Yan C, et al. Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One. 2013;8:e64607.
– reference: 24. Touati A, Blouin Y, Sirand-Pugnet P, et al. Molecular epidemiology of Mycoplasma pneumoniae: genotyping using single nucleotide polymorphisms and SNaPshot technology. J Clin Microbiol. 2015;53:3182-94.
– reference: 11. Xue G, Wang Q, Yan C, et al. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J Clin Microbiol. 2014;52:1478-82.
– reference: 25. Suzuki Y, Itagaki T, Seto J, et al. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32:237-40.
– reference: 26. Cousin-Allery A, Charron A, de Barbeyrac B, et al. Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect. 2000;124:103-11.
– reference: 9. Sun H, Xue G, Yan C, et al. Changes in molecular characteristics of Mycoplasma pneumoniae in clinical specimens from children in Beijing between 2003 and 2015. PLoS One. 2017;12:e0170253.
– reference: 33. Zhang J, Song X, Ma MJ, et al. Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data. Future Microbiol. 2017;12:119-29.
– reference: 7. Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol. 2016;7:693.
– reference: 19. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72.
– reference: 32. Diaz MH, Desai HP, Morrison SS, et al. Comprehensive bioinformatics analysis of Mycoplasma pneumoniae genomes to investigate underlying population structure and type-specific determinants. PLoS One. 2017;12:e0174701.
– reference: 4. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471-7.
– reference: 23. Kubota H, Okuno R, Hatakeyama K, et al. Moleculer typing of Mycoplasma pneumoniae isolated from pediatric patients in Tokyo, Japan. Jpn J Infect Dis. 2015;68:76-8.
– reference: 16. Kenri T, Ohya H, Horino A, et al. Identification of Mycoplasma pneumoniae type 2b variant strains in Japan. J Med Microbiol. 2012;61:1633-5.
– reference: 20. Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53:124-30.
– reference: 30. Qu J, Yu X, Liu Y, et al. Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One. 2013;8:e82174.
– reference: 15. Kenri T, Horino A, Matsui M, et al. Complete genome sequence of Mycoplasma pneumoniae type 2a strain 309, isolated in Japan. J Bacteriol. 2012;194:1253-4.
– reference: 29. Ministry of Health, Labour and Welfare and National Institute of Infectious Disease. Mycoplasma Pneumonia. Available at <https://www.niid.go.jp/niid/en/10/2096-weeklygraph/1659-18 myco.html>. Accessed April 9, 2017. Japanese.
– reference: 28. Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48:460-5.
– reference: 17. Zhao F, Cao B, Li J, et al. Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J Clin Microbiol. 2011;49:3000-3.
– reference: 27. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-20.
– reference: 22. Suzuki Y, Seto J, Itagaki T, et al. Gene mutations associated with macrolide-resistance p1 gene typing of Mycoplasma pneumoniae isolated in Yamagata, Japan, between 2004 and 2013. Kansenshogaku Zasshi 2015;89:16-22. Japanese.
– reference: 8. Chalker VJ, Pereyre S, Dumke R, et al. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37-40.
– reference: 2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
– reference: 18. Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974.
– reference: 3. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17:S37-46.
– reference: 14. Sasaki T, Kenri T, Okazaki N, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996;34:447-9.
– reference: 21. Dumke R, Schnee C, Pletz MW, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011–2012. Emerg Infect Dis. 2015;21:426-34.
– reference: 5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9:109-14.
– ident: 16
  doi: 10.1099/jmm.0.046441-0
– ident: 32
  doi: 10.1371/journal.pone.0174701
– ident: 11
  doi: 10.1128/JCM.03366-13
– ident: 4
  doi: 10.1097/00006454-199506000-00002
– ident: 28
  doi: 10.1128/AAC.48.2.460-465.2004
– ident: 17
  doi: 10.1128/JCM.00105-11
– ident: 22
  doi: 10.11150/kansenshogakuzasshi.89.16
– ident: 31
  doi: 10.1128/JCM.00350-17
– ident: 13
  doi: 10.1093/ofid/ofv106
– ident: 19
  doi: 10.1086/511159
– ident: 23
  doi: 10.7883/yoken.JJID.2014.336
– ident: 30
  doi: 10.1371/journal.pone.0082174
– ident: 10
  doi: 10.1128/JCM.01983-15
– ident: 24
  doi: 10.1128/JCM.01156-15
– ident: 18
  doi: 10.3389/fmicb.2016.00974
– ident: 25
  doi: 10.1097/INF.0b013e31827aa7bd
– ident: 7
– ident: 1
  doi: 10.1111/j.1574-6976.2008.00129.x
– ident: 6
  doi: 10.1128/JCM.01935-08
– ident: 3
  doi: 10.1093/clinids/17.Supplement_1.S37
– ident: 33
  doi: 10.2217/fmb-2016-0111
– ident: 26
  doi: 10.1017/S0950268899003313
– ident: 9
  doi: 10.1371/journal.pone.0170253
– ident: 21
  doi: 10.3201/eid2103.140927
– ident: 20
  doi: 10.1128/JCM.02597-14
– ident: 29
– ident: 12
  doi: 10.1371/journal.pone.0064607
– ident: 14
  doi: 10.1128/JCM.34.2.447-449.1996
– ident: 27
  doi: 10.1111/j.1348-0421.2001.tb01293.x
– ident: 8
  doi: 10.1016/j.nmni.2015.05.005
– ident: 15
  doi: 10.1128/JB.06553-11
– ident: 2
  doi: 10.1128/CMR.17.4.697-728.2004
– ident: 5
  doi: 10.1111/j.1440-1843.2003.00522.x
SSID ssj0025510
Score 2.205244
Snippet Multiple-locus variable-number tandem-repeat analysis (MLVA) typing was performed for Mycoplasma pneumoniae strains isolated between 2004 and 2014 in Yamagata,...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 642
SubjectTerms DNA, Bacterial
History, 21st Century
Humans
Japan - epidemiology
Loci
macrolide resistance
Macrolides - pharmacology
Microbial Sensitivity Tests
Minisatellite Repeats
MLVA
molecular epidemiology
Multilocus Sequence Typing
Mutation
Mycoplasma pneumoniae
Mycoplasma pneumoniae - classification
Mycoplasma pneumoniae - drug effects
Mycoplasma pneumoniae - genetics
Mycoplasma pneumoniae - isolation & purification
P1 type
Pneumonia, Mycoplasma - epidemiology
Pneumonia, Mycoplasma - history
Pneumonia, Mycoplasma - microbiology
Prevalence
Public Health Surveillance
Typing
VNTR
Title Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period
URI https://www.jstage.jst.go.jp/article/yoken/70/6/70_JJID.2017.276/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/29093323
https://www.proquest.com/docview/2013149498
https://www.proquest.com/docview/1959321846
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Infectious Diseases, 2017, Vol.70(6), pp.642-646
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe6gRAviG8KAxmJty4lH67j8Man1opOSHSofYqcxN260aSiyUP3x_G3cRc7XluVifFiRbZ7cnq_2Hfn-yDkjRKhP41S12Ghy6DxAifKpIAPL3XxmixLfAxwHh7zoxM2GPfGrb3WmtdSVSbd9HJnXMn_cBX6gK8YJXsDzlqi0AHPwF9ogcPQ_hOPh8Yb0PlapNWy8wP0XoyEco7rMh-dERqI5w7I2GgGWE8_MlylxQLk5rnsLHJVwYJnUnX6sFoUPa3zFv4L9e0CnN8MLSMTOZensjT-tbCRoEFBByjg8LCptVvf4q_ngbbRkB3Pc1aYPOgbjBUbVUJrgmqpNrNZaF8xeDtzlWR1gO_VZaVrbk8q26dKfZNU5ecz23mGeNRltyfF8mxWygt7GPVLeCFNZrSsymJerdtBdMCn2bQDxhwe6DLGXaX7hGAOiE58fafXJUoMote3ba4zfBkJgGuj6PbhEgqBSS5WxYXKu4NB_xM6BoZdP9yRynvriLWOj6ByIZm4JhIjkRiJxEBkj9zyQdWpy4-MrZsSaHw6o0bzjjpzFhJ5u2MlG9LV7XNQME7V33WnWoYa3Sf3jPJD32skPyAtlT8kd4bGveMR-b0JaLoFaLoBaNoAmhZTegVoegVo2gCaGkBTBDQFIhQBTWc5bQB9SGv0vaMazDhkwUy3wEw1mIEONWCmGsyPycmXz6OPR44pMOKk3BOlM00iIaMsCHoK2kiKVLoyEzLjUgZqmnggKni8l2Q-98NE9EImspSJqOfyFCs5BE_Ifl7k6hmhmVJJ2hPcj5hiXhjAbB55jMkoCXCsTfyGMXFqsu9jEZif8TWQaJND-6OFTj5z_fQPmuN2stmZzOTQjTk2Gz-yczDKEzbVNjlo0BKbz32JkwMP81iJNnlth-EgwttF2BpgF4gxS1WABiNYx1ONMrsOP0LDqR88v9kLvSB38VFbPA_IfvmrUi9BByiTV_VH8gf-JAvr
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple-Locus+Variable-Number+Tandem-Repeat+Analysis+of+Mycoplasma+pneumoniae+Isolates+between+2004+and+2014+in+Yamagata%2C+Japan%3A+Change+in+Molecular+Characteristics+during+an+11-year+Period&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Suzuki%2C+Yu&rft.au=Seto%2C+Junji&rft.au=Shimotai%2C+Yoshitaka&rft.au=Itagaki%2C+Tsutomu&rft.date=2017&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=70&rft.issue=6&rft.spage=642&rft.epage=646&rft_id=info:doi/10.7883%2Fyoken.JJID.2017.276&rft.externalDBID=n%2Fa&rft.externalDocID=10_7883_yoken_JJID_2017_276
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon